{
    "2021-12-06": [
        [
            {
                "time": "2021-11-30",
                "original_text": "Moderna Stock Dropped. The Omicron Picture Is Getting Slightly Less Hazy.",
                "features": {
                    "keywords": [
                        "Moderna",
                        "Omicron",
                        "Dropped"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response -UK study",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "AstraZ",
                        "Moderna",
                        "immune response",
                        "study"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "Bright Path CEO explains the importance of producing pharmaceutical drugs in the U.S.",
                "features": {
                    "keywords": [
                        "pharmaceutical",
                        "U.S.",
                        "importance"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "Vaccine Stocks Moderna, BioNTech Crumble; Why Omicron Might Not Sway Holdouts",
                "features": {
                    "keywords": [
                        "Vaccine Stocks",
                        "Moderna",
                        "BioNTech",
                        "Omicron",
                        "Crumble"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "COVID testing remains 'troublesome' in various areas of the U.S., doctor explains",
                "features": {
                    "keywords": [
                        "COVID testing",
                        "troublesome",
                        "U.S."
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "Why Shares of Pfizer, Ocugen, and Vaxart Are Losing Ground Today",
                "features": {
                    "keywords": [
                        "Shares",
                        "Pfizer",
                        "Ocugen",
                        "Vaxart",
                        "Losing Ground"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "Moderna Stock Drops. The Omicron Picture Is Getting Slightly Less Hazy.",
                "features": {
                    "keywords": [
                        "Moderna",
                        "Omicron",
                        "Drops"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "Omicron variant: We donâ€™t need to go into panic mode right now, physician says",
                "features": {
                    "keywords": [
                        "Omicron",
                        "panic mode",
                        "physician"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "COVID: NYC expands vaccine mandate to include children",
                "features": {
                    "keywords": [
                        "COVID",
                        "NYC",
                        "vaccine mandate",
                        "children"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "How millions of COVID vaccines are paid for",
                "features": {
                    "keywords": [
                        "COVID vaccines",
                        "paid for"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "J&J (JNJ) COVID-19 Booster Jab Compares Well With Comirnaty",
                "features": {
                    "keywords": [
                        "J&J",
                        "Booster Jab",
                        "Comirnaty"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "AbbVie (ABBV) Adds FDA-Issued New Warnings to Rinvoq's Label",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "FDA",
                        "Warnings",
                        "Rinvoq"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "UPDATE 1-South Africa's Biovac to start making Pfizer-BioNTech COVID-19 vaccine in early 2022 - exec",
                "features": {
                    "keywords": [
                        "South Africa",
                        "Biovac",
                        "Pfizer-BioNTech",
                        "vaccine"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "Dow Jones Rallies, Tech Stocks Sell Off; Lucid Plunges 15% On SEC Probe; Tesla Falls To Key Support",
                "features": {
                    "keywords": [
                        "Dow Jones",
                        "Tech Stocks",
                        "Lucid",
                        "Tesla",
                        "SEC Probe"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "automotive"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "Dow Jones Futures Rally; Bitcoin Stumbles; Lucid Dives On SEC Probe; Tesla Nears Key Support",
                "features": {
                    "keywords": [
                        "Dow Jones Futures",
                        "Bitcoin",
                        "Lucid",
                        "Tesla",
                        "SEC Probe"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "cryptocurrency"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "South Africa's Biovac to start making Pfizer-BioNTech COVID-19 vaccine in early 2022 - exec",
                "features": {
                    "keywords": [
                        "South Africa",
                        "Biovac",
                        "Pfizer-BioNTech",
                        "vaccine"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "14 Stocks Skate Right Through The Market's Sell-Off",
                "features": {
                    "keywords": [
                        "Stocks",
                        "Sell-Off"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "The Zacks Analyst Blog Highlights: Moderna, Pfizer, BioNTech, J&J and Regeneron",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst Blog",
                        "Moderna",
                        "Pfizer",
                        "BioNTech",
                        "J&J",
                        "Regeneron"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "Pfizer and Merck Covid-19 Pills Are Coming Soon in the U.S., but Other Countries Will Have to Wait",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Merck",
                        "Covid-19 Pills",
                        "U.S."
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "INSIGHT-COVID shots are finally arriving, but Africa can't get them all into arms",
                "features": {
                    "keywords": [
                        "COVID shots",
                        "Africa",
                        "arriving"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}